Zafer Tandogdu: Can TXA Redefine Bleeding Management in Urology
Zafer Tandogdu, Consultant Urologist, Member of Uro-oncology Robotic Surgery Team at University College London Hospitals NHS Foundation Trust, Senior Researcher and co-founder of UTISOLVE Research Group, shared Daniel Jiménez Peralta’s post on LinkedIn:
“Shout it from the rooftops: tranexamic acid reduces surgical bleeding, transfusion need, and major bleeding — without an observed increase in thromboembolic events.
Use it thoughtfully, but don’t fear it reflexively.”
Daniel Jiménez Peralta, Digital Health Office Collaborator at Spanish Association of Urology, Urologist at the La Rioja Health Service, shared a post on LinkedIn:
“Everything we assumed about tranexamic acid in urology had never really been proven.
Until now.
Kari Tikkinen — thank you for bringing this question to the table.
For years, young urologists like me saw tranexamic acid being used by other specialties during high risk of bleeding while we looked the other way.
The EAU and AUA guidelines did not clearly recommend it.
The prior evidence was inconsistent.
And the fear of thrombotic events outweighed the perceived benefit.
Until the urology subgroup analysis of POISE-3 arrived.
- 1,124 patients.
- High cardiovascular-risk urologic surgery.
- 1 g of TXA at induction plus 1 g at closure.
The results:
- Major bleeding: 6.1 percent versus 9.5 percent (HR 0.63)
- 37 percent relative risk reduction
- No clear signal of increased thrombotic events
What does this mean in practice?
For every 1,000 patients operated on, 34 major bleeds avoided.
In cystectomies. In open nephrectomies. In older patients with cardiovascular risk and on antithrombotic therapy.
TXA is inexpensive. It’s accessible. And now it has robust evidence.
Are you already using it in your department?
What has your experience been?”
Stay updated with Hemostasis Today.
-
May 17, 2026, 12:19Amna Idrees: Reducing Surgical Blood Loss in Children Through Perioperative TXA
-
May 17, 2026, 12:03Heghine Khachatryan: 79th World Health Assembly Side Event – ‘Advancing Health Equity for Bleeding Disorders’
-
May 17, 2026, 11:42Côme Bommier: A Pocket Guide for Hematology Emergencies and Urgent Care
-
May 17, 2026, 11:26Auston Cherbonneaux: Coffee-Associated Microbiome Alterations and Clinical Implications
-
May 17, 2026, 11:14Changing the Future of PNH Care Through Global Collaboration – The Max Foundation
-
May 17, 2026, 11:04Owen McCarty: Few Insights and Implications from Recent Clinical Trials of FXI Inhibitors
-
May 17, 2026, 10:55National Phlebotomist Week and the People Powering Patient Care – Northwell Health
-
May 17, 2026, 10:54Amanda Unsworth: Discovering Heart and Thrombosis Science at Be Curious
-
May 17, 2026, 10:50Urs Fischer: Could a Three-in-One Pill Improve Outcomes After Brain Bleeding